HORIZON-HLTH-2027-01-DISEASE-05 novel small-molecule antiviral therapeutics for pathogens with epidemic potential
European Commission, Horizon Europe Cluster 1
Shared attributes
- Funding type: Grant
- Area: Infectious disease
Programme recordGL-CARBX
Funding Atlas programme
CARB-X funding rounds for early-stage antibacterial products
CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator, Boston University)
Funding typeGrantJurisdictionGlobalAreasInfectious disease
Documented facts
Key facts
- Funder
- CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator, Boston University)
- Programme
- CARB-X funding rounds for early-stage antibacterial products
- Jurisdiction
- Global
- Funding type
- Grant
- Therapeutic areas
- Infectious disease
Source-bound timeline
Supplied dates
These dates were recorded in the Atlas as of 3 October 2026. Confirm current timing with the funder.
- Expressions of interest close (window opens 10 Nov; reported)